Dermata Therapeutics Warrant Stock Shares Outstanding
| DRMAW Stock | USD 0.02 0.0001 0.50% |
Fundamental analysis of Dermata Therapeutics allows traders to better anticipate movements in Dermata Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Dermata Therapeutics Warrant Company Shares Outstanding Analysis
Dermata Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Dermata Therapeutics Warrant has 0.0 of shares currently outstending. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Dermata Fundamentals
| Return On Equity | -2.06 | ||||
| Return On Asset | -0.96 | ||||
| Number Of Shares Shorted | 300 | ||||
| EBITDA | (12.29 M) | ||||
| Net Income | (12.29 M) | ||||
| Total Debt | 1.97 M | ||||
| Book Value Per Share | 12.10 X | ||||
| Cash Flow From Operations | (11.16 M) | ||||
| Earnings Per Share | (2.16) X | ||||
| Beta | 0.53 | ||||
| Total Asset | 3.53 M | ||||
| Retained Earnings | (65.68 M) | ||||
| Working Capital | 1.56 M | ||||
| Net Asset | 3.53 M |
About Dermata Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dermata Therapeutics Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dermata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dermata Therapeutics Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.